Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

151.94 -1.86 (-1.21%)
Streaming Delayed Price Updated: 12:23 PM EDT, Jul 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
7 Dividend Stocks to Buy in July 2022
Dividend stocks are only becoming more attractive as income becomes increasingly paramount. These seven equities pair dividends with safety. 
Via InvestorPlace
Check Out What Whales Are Doing With ABBV
Someone with a lot of money to spend has taken a bullish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Analyzing AbbVie's Short Interest
AbbVie's (NYSE:ABBV) short percent of float has risen 27.78% since its last report. The company recently reported that it has 13.52 million shares sold short, which is 0.92%... 
Via Benzinga
AbbVie Stock’s Healthy Yield Makes it a High-Conviction Holding
Between the dividend payouts and the potential price appreciation, ABBV stock could be a pharma-market winner in 2022. 
Via InvestorPlace
Top 3 Dividend Stocks For Any Market
As inflation heats up and the Fed raises interest rates, now is the time to check out AbbVie, Enterprise Product Partners, and NextEra Energy Partners. 
Via Talk Markets
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 6.01% on an annualized basis producing an average annual return of 15.88%. Currently, AbbVie has a market capitalization of... 
Via Benzinga
AbbVie Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 29 strange trades. 
Via Benzinga
AbbVie - Genmab Present Epcoritamab Data From Lymphoma Trial
 
Via Benzinga
Consistent Clinical Results Indicate Upside for AbbVie Stock
ABBV stock trades at a reasonable valuation and can move higher. Meanwhile, AbbVie's financials and dividend payments sweeten the deal. 
Via InvestorPlace
AbbVie Whale Trades Spotted
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
Via InvestorPlace
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
AbbVie Whale Trades For June 01
A whale with a lot of money to spend has taken a noticeably bullish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 10 strange trades. 
Via Benzinga
Why AbbVie Stock Is Trading Higher Today
AbbVie Inc (NYSE: ABBV) shares are trading higher Tuesday after the company announced it submitted a supplemental New Drug Application for atogepant to the U.S. Food and Drug Administration to support... 
Via Benzinga
Jim Cramer Says This Is A Terrific Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rapid7, Inc. (NASDAQ: RPD) doesn’t make money, so he will not go for it. 
Via Benzinga
The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
AbbVie Whale Trades For June 14
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
7 Dividend Stocks to Buy for Your Grandkids
If this roiling market is making you seasick, then it's an excellent time to batten down the hatches with these reliable dividend stocks. 
Via InvestorPlace
7 Great ETFs to Buy Now for Momentum in Q2
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments. 
Via InvestorPlace
3 Dividend Stocks to Buy Now for 20 Years of Income Growth
Investors looking for passive income from holding stocks should consider these dividend stocks that offer strong payouts. 
Via InvestorPlace
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 5.42% on an annualized basis producing an average annual return of 16.4%. Currently, AbbVie has a market capitalization of... 
Via Benzinga
Johnson & Johnson-AbbVie Partnered Lymphoma Drug Slows Disease Progression, Data Shows
 
Via Benzinga
It’s a Market of Stocks Not a Stock Market
Stocks are as individual as people. What really matters, in the long run, is how well the business is operated, which will always be reflected in the fundamentals. 
Via Talk Markets
7 Safe Dividend Stocks With High Yields to Buy Now
Investors are seeking dividend stocks. Here are seven safe dividend stocks that offer a high yield to maximize their total return. 
Via InvestorPlace
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... 
Via Benzinga
The 3 Best Performing ETFs Money Can Buy in 2022
These are the best-performing ETFs of 2022. EFDL, DHS and RYE can make great investments in the rest of 2022. 
Via InvestorPlace
Overvaluation Is An Obvious Mistake That Can And Should Be Avoided
Massive overvaluation is vulnerable to even the hint of bad news. Almost any negative catalyst can cause havoc to the stock price. 
Via Talk Markets
7 High-Yield Retirement Stocks to Buy for Your Nest Egg
These 7 high-yield retirement stocks to buy are among a list of companies that are dividend aristocrats and offer great dividends. 
Via InvestorPlace
7 Ideal Dividend Stocks to Buy for a Rich Retirement
These dividend stocks to buy will enable you to offset your portfolio risk and ensure you don't outlive your savings. 
Via InvestorPlace
Teva, Allergan Settle Opioid Lawsuit With West Virginia
U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.